Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by eric40on Apr 30, 2018 9:17am
244 Views
Post# 27957703

RE:News : Reformatted

RE:News : ReformattedIVIG comes third in the PPPS extraction after plasminogene and fibrinogen if I am not mistaking. Also, I doubt that IVIG will be approuved in Canada before Ryplazim is approuved in US as Ryplazim approuval comes with PPPS process approuval with its news control check point. When I last talked with Fred and Simon Best, I was told they expect Ryplazim approuval the later end of H1 2019 to be conservative. So I don't see a Canadian approuval of IVIG before H2-2019 to be also conservative.

Also, I believe there could be a painfull financing coming (hopefully the last) in order to be in a stronger position to make a deal. Prometic is not going to wait until they have there back against the wall (I know they are already close to that wall!) to proceed unless they come with a deal with some upfront cash. But with a weak cash position, I believe they have no choice but to make a financing even at these level. That is what the market seems to think as well.

The AGM will be tough for the management this year, but next year should be much better.

Hopefully todays news wont follow the usual good news-lower SP as usual !!!

GLTA 
Bullboard Posts